Furthermore, our data demonstrated that low PTPRM expression is associated with poor overall survival (Fig. 5A) and PTPRM methylation marks maybe used as biomarkers for JAK/STAT targeting anti-cancer drugs response. Here, PTPRM is linked to cancer.